Clinical Trials Arena

The World Health Organization’s (WHO) new framework aimed at strengthening clinical trial systems addresses a global issue of “major research waste”, according to Vasee Moorthy, senior advisor of research and development at World Health Organization. Click here for the full article - https://lnkd.in/dz_mu-RU #clinicaltrials #researchwaste Outsourcing in Clinical Trials Event Series

California-based clinical development company Medable, Inc has announced a partnership with technology giant Google Cloud to bring the company’s digital, decentralised clinical trial platform to the Google Cloud Marketplace. Michelle Longmire, co-founder, and CEO of Medable, said: “This alliance provides life sciences companies with Medable’s cutting-edge clinical development technology powered by Google Cloud through Google Cloud Marketplace. The collaboration will enable scaled and seamless adoption of Medable solutions by Google Cloud users, providing life sciences companies with platform capabilities proven to improve patient access to trials and accelerate critical development efforts, globally.” Dai Vu, managing director of Google Cloud Marketplace, said: “Bringing Medable’s platform to Google Cloud Marketplace will help customers quickly deploy, manage, and expand their use of the AI-driven clinical trial platform on Google Cloud’s trusted, global infrastructure.” Click here for the full article - https://lnkd.in/dykyTtXA #clinicaltrials #clinicalresearch #cloudtechnology #DCTs #decentralizedclinicaltrials #decentralizedtrials #ai #aiinhealthcare

Roche has presented new late-breaking data from a prospective trial showing that its Elecsys amyloid plasma panel can rule out Alzheimer’s disease with a high negative predictive value (NPV) of 96.2%. Click here for the full article - https://lnkd.in/dwfpjW-V #clinicaltrials #alzheimers #pharma

Despite stringent European Union (EU) laws governing smaller medical device and pharma companies, the DACH region can be an attractive place to conduct clinical trials, according to industry leaders. Andrea Sauerland, senior vice-president of clinical operations at Endotronix, Enrico Perfler, founder of medtech contract research organisation (CRO) 1MED SA and Ina Meyer, study and site operations country manager for Switzerland at Novartis were speaking at our Annual Outsourcing in Clinical Trials DACH 2024 event which is taking place in Zurich, Switzerland, on 29–30 October. Click here for the full article - https://lnkd.in/gWKMSeT5 #clinicaltrials #clinicaloperations #contractresearch #CRO #medtech Outsourcing in Clinical Trials Event Series Arena International Events Group #pharma

Questions remain over costs and the participant experience when it comes to community-based research sites. However, conducting research in the community could create a more cost-effective and positive trial experience with fewer participant dropouts. Learn more in this article form PCM TRIALS - Quality Mobile Research - https://lnkd.in/d5S69jSR #clinicaltrials #clinicalresearch #DCTs #decentralizedclinicaltrials

Moderna and MSD have initiated a Phase III clinical study to evaluate mRNA-4157 (V940), an investigational individualised neoantigen therapy, in combination with Keytruda to treat non-small cell lung cancer (NSCLC). MSD Research Laboratories oncology and global clinical development senior vice-president and head Dr Marjorie Green said:“We are pleased to expand the INTerpath clinical trial programme with Moderna, evaluating V940 (mRNA-4157), a promising new modality, in combination with Keytruda to pursue meaningful advances for lung cancer and bring more options to patients with earlier stages of disease, where we potentially can have the most impact.” Click here for the full article - https://lnkd.in/dJC3_uCf #clinicaltrials #keytruda #lungcancer #oncology #mRNA

Our reporter Jenna Philpott is at the Outsourcing in Clinical Trials Event Series DACH conference in Zurich, Switzerland today and tomorrow. Great start to the day with sessions covering the ICH GCP E6 (R3) guidelines and patient centricity.

The United Arab Emirates (UAE)’s clinical research landscape, is quickly developing with a regulatory framework coming into place over the last few years, said Rohan Simon, associate director of business development at IROS CRO by M42 Health, the UAE’s first contract research organisation (CRO). Simon discussed the ins and outs of the UAE’s clinical trials ecosystem at our Outsourcing in Clinical Trials Conference in New England. Click here for the full article - https://lnkd.in/dQpD52-2 #UAEhealthcare #pharma #clinicaltrials #CRO #contractresearch #clinicaloutsourcing #clinicalresearch

Social media has become an excellent tool for targeting specific patients for clinical trials, says Chris Adams, C. - Andarix, the CEO at Andarix Pharmaceuticals, a biotech developing targeted oncology therapies. Adams was speaking at our Outsourcing in Clinical Trials conference in Boston, New England, being held 23 – 24 October, where experts discussed challenges and strategies surrounding clinical trial operations. Click here for the full article - https://lnkd.in/dwyiqKxM #clinicaltrials #pharma #raredisease #socialmedia #oncology

The pharmaceutical industry is undergoing significant changes, with clinical trials becoming increasingly complex and extending beyond traditional geographical boundaries. Novotech, a well-established global contract research organization (CRO), has been recognized for its strategic approach to navigating these changes, earning awards in Business Expansion, Innovation, and Marketing categories in the 2024 Clinical Trials Arena Excellence Awards. Novotech won the Business Expansion award for its strategic acquisitions and the launch of specialized units that enhance its international presence and service offerings. The Innovation award was given for Novotech’s adoption of advanced technologies such as artificial intelligence (AI) and big data to optimize clinical trial design and execution. The Marketing awards were earned through visionary leadership that successfully rebranded Novotech as a global CRO, with targeted multi-channel marketing strategies that resonated across diverse markets. Find out more here - https://lnkd.in/e75ZTtjE